Hydrocortisone cream can modestly improve the appearance of certain scars, but it is far from the most effective option available. Over-the-counter 1% hydrocortisone works primarily by calming inflammation, reducing redness, and slightly suppressing the collagen overproduction that makes scars raised and thick. For flat, mature scars that have already settled, it does very little. Its real usefulness is narrow: early-stage scars that are still red and inflamed, post-procedure skin where pigmentation changes are a concern, and mild itching or discomfort from healing tissue. The story gets more interesting when you look at why topical steroids underperform compared to other delivery methods and where hydrocortisone fits in a broader scar-management plan.
What Hydrocortisone Actually Does to Scar Tissue
Scars form when the body overproduces collagen during wound repair. The new collagen fibers are laid down in a disorganized pattern, creating tissue that looks and feels different from normal skin. Corticosteroids like hydrocortisone interfere with this process at several points. They slow down fibroblast proliferation, which means fewer of the cells responsible for making collagen are active in the wound area. They also suppress collagen synthesis directly by dialing down the signals that tell cells to produce type I and type III collagen, the two main types found in scar tissue.1PubMed Central. The application of corticosteroids for pathological scar prevention and treatment: current review and update
Animal studies have shown that hydrocortisone specifically decreases collagen content and inhibits the development of new blood vessels in healing tissue, especially during the early inflammatory phase of wound repair.2PubMed. Comparison of the effects of methylprednisolone and hydrocortisone on granulation tissue development Older research found that cortisol, the natural hormone hydrocortisone mimics, actively inhibits fibroblast proliferation in tissue culture, and that its levels in healing wounds naturally rise at a time when they can prevent fibroblasts from going into overdrive.3Journal of Investigative Dermatology. Corticosteroid Metabolism During Wound Healing So the biological rationale is sound. The problem is getting the drug where it needs to go.
The Penetration Problem
Scar tissue, especially the dense, fibrous kind found in keloids and raised hypertrophic scars, is notoriously difficult for topical creams to penetrate. The tight collagen matrix acts as a barrier, and a standard hydrocortisone cream applied to the surface simply does not deliver enough active ingredient to the deeper layers where fibroblasts are busiest. This is the main reason dermatologists tend to favor intralesional injections of stronger corticosteroids like triamcinolone acetonide for problem scars. A needle bypasses the barrier entirely and deposits the drug right where it is needed.
A systematic review of randomized trials treating keloids and hypertrophic scars found that intralesional injection had an effectiveness rate of about 64%, compared to roughly 34% for topical treatments.4PubMed. Treatment of traumatic hypertrophic scars and keloids: a systematic review of randomized control trials That is a significant gap, and it largely comes down to drug delivery. The active ingredient in a topical formulation is the same class of molecule. It just cannot reach the target tissue in sufficient concentration through the skin’s surface. Research on scar treatment has increasingly focused on developing topical formulations with better transdermal efficiency for this reason.5Burns & Trauma. The application of corticosteroids for pathological scar prevention and treatment: current review and update
Where Topical Hydrocortisone Performs Best
The cream does appear to help with fresh, still-developing scars where the tissue is thin enough to allow some penetration and where inflammation is the main driver of the scar’s appearance. A clinical trial on women who had cesarean sections found that applying a corticosteroid ointment to the incision site reduced scar height and vascularity (the redness caused by blood vessels) at three months compared to untreated controls. By six months, though, the difference had evened out.6PubMed Central. Assessment of topical corticosteroid ointment on postcesarean scars prevention: A prospective clinical trial This suggests that topical steroids can speed up the natural flattening and fading process in fresh surgical scars, but they do not necessarily change the final outcome once the scar has fully matured.
That early-phase window is important. If you are dealing with a new scar that is red, slightly raised, and itchy, hydrocortisone cream can take the edge off those symptoms and may help the scar settle faster. If you are looking at a scar that has been there for years and is already pale and flat, the cream is unlikely to do much of anything.
Timing, Wound Strength, and Why You Shouldn’t Start Too Early
One of the genuine risks of applying hydrocortisone cream to healing skin is that corticosteroids weaken wound closure in the early days after injury. An experimental study found that corticosteroid-treated wounds had significantly lower tensile strength on the seventh day after surgery compared to untreated wounds. By the fourteenth and twenty-first days, wound strength had caught up and there was no longer a meaningful difference.7Acta Cirúrgica Brasileira. Influence of local or systemic corticosteroids on skin wound healing resistance
What this means in practice is that you should not slather hydrocortisone on a wound that has not yet closed or on stitches that are still holding tissue together. The same anti-inflammatory properties that make it useful for mature scar tissue can actively interfere with the healing process when tissue is still knitting together. Most dermatologists recommend waiting until sutures are out and the wound has fully re-epithelialized before introducing any steroid product. For surgical scars, that typically means at least two to three weeks post-procedure, depending on the location and how quickly you heal.
Hydrocortisone Compared to Silicone Products
Silicone gel sheets and silicone-based creams are the most widely recommended first-line topical treatment for scars, and their evidence base is considerably broader than that of topical steroids. So how does hydrocortisone stack up head-to-head?
A randomized double-blind trial comparing topical hydrocortisone 1% ointment to a silicone 5% hydrogel for keloid scars found no significant difference between the two in either patient or observer scar scores.8Iranian Journal of Dermatology. Efficacy of topical silicone 5% hydrogel vs. topical hydrocortisone 1% ointment in keloid treatment measured using POSAS score Both produced modest improvements, but neither was dramatically better than the other for keloids. A separate trial on Pfannenstiel (bikini-line cesarean) scars compared a methylprednisolone cream, a silicone gel, and no treatment. At six months, the steroid cream outperformed both the silicone group and the control group across scar height, vascularity, and pigmentation, and patient satisfaction was highest in the steroid group.9PubMed. Comparison of the effectiveness of topical silicone gel and corticosteroid cream on the pfannenstiel scar prevention – a randomized controlled trial
The picture that emerges is context-dependent. For keloids, which are thick and hard for any topical to penetrate, hydrocortisone and silicone perform about equally, which is to say modestly. For thinner surgical scars where the tissue is not as dense, a topical steroid may have a slight edge. It is worth noting that the Pfannenstiel trial used methylprednisolone, a stronger steroid than hydrocortisone, so those results do not translate directly to over-the-counter 1% hydrocortisone cream. Potency matters.
The Role in Preventing Post-Inflammatory Hyperpigmentation
One of the more useful applications of topical hydrocortisone around scars has less to do with the scar tissue itself and more to do with the dark spots that can form after skin inflammation. Post-inflammatory hyperpigmentation, or PIH, is a common concern for people with darker skin tones. Any kind of injury, surgery, or skin procedure can trigger excess melanin production in the surrounding skin, leaving dark patches that linger for months or even years.
A split-face study on patients who underwent ablative fractional laser resurfacing found that sides of the face treated with a topical corticosteroid plus petrolatum had a 40% rate of PIH, compared to 75% on the sides treated with petrolatum alone. The hyperpigmentation that did develop on the steroid-treated side was also less intense and covered a smaller area.10Acta Dermato-Venereologica. Topical Corticosteroids Minimise the Risk of Postinflammatory Hyperpigmentation After Ablative Fractional CO2 Laser Resurfacing in Asians This is a specific and meaningful benefit: short-term steroid use after a skin procedure to reduce the risk of pigmentation problems.
However, topical corticosteroids are not a strong standalone treatment for PIH that has already established itself. A systematic review of PIH prevention in skin of color found less successful outcomes when topical corticosteroids were used on their own.11PubMed Central. Prevention of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review The benefit seems to be preventive, applied shortly after the triggering event, rather than corrective once discoloration has set in. In combination formulas like the modified Kligman regimen, which pairs hydrocortisone with hydroquinone and tretinoin, the steroid plays a supporting anti-inflammatory role rather than acting as the primary lightening agent.12PubMed. Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study
Risks of Using Hydrocortisone Cream on Scars Long-Term
Over-the-counter hydrocortisone is a low-potency steroid, and short-term use on intact skin is generally safe. The trouble starts when people use it for weeks or months at a time, which is what scar treatment often demands. Prolonged topical corticosteroid use can cause skin atrophy (thinning), stretch marks, broken capillaries, acne-like eruptions, and changes in pigmentation. These effects depend on the potency of the steroid, the body location, and how long it is used.13PubMed. Adverse effects of topical glucocorticosteroids
Thin-skinned areas like the face, neck, and inner arms are particularly vulnerable. The eyelids, for instance, can develop visible thinning in a matter of weeks with regular steroid application. Thicker-skinned areas like the back or limbs are more forgiving, but still not immune to prolonged use. If you are treating a facial scar, the window of safe continuous use is short, generally a couple of weeks at most for hydrocortisone 1%. For body scars, you have a bit more leeway, but ongoing use beyond a few weeks should be discussed with a dermatologist.
There is an ironic twist here: one of the side effects of prolonged corticosteroid use, skin atrophy, is actually the mechanism being exploited to flatten raised scars. The line between therapeutic thinning of excessive scar tissue and pathological thinning of healthy surrounding skin is not always easy to control with a cream applied to a broad area. Injections, by contrast, can target the scar tissue precisely without affecting the normal skin around it.
Children and Sensitive Skin
Children’s skin absorbs topical medications more readily than adult skin because it is thinner and has a higher surface-area-to-body-weight ratio. This makes pediatric patients more susceptible to both the local side effects, like skin thinning and stretch marks, and potential systemic absorption of corticosteroids.14Discover Medicine. Optimized and safe use of topical corticosteroids in pediatric dermatology through interdisciplinary collaboration: a review If you are considering hydrocortisone cream for a child’s scar, keep applications brief and limited in area. A pediatric dermatologist can help weigh the benefit of scar improvement against the risk of steroid side effects, especially for scars on the face or in skin folds where absorption is highest.
Steroid Tape and Newer Delivery Methods
One of the more promising developments in topical steroid delivery for scars is corticosteroid-impregnated tape. These adhesive strips contain a steroid (commonly fludroxycortide) embedded in the adhesive layer. The tape creates an occlusive environment that increases drug absorption into the scar while also providing the pressure and hydration benefits of silicone sheeting. Early studies on steroid tapes in dermatological conditions showed them to be equal or superior to cream formulations, with patients preferring the convenience and better adherence. In one study of a chronic skin condition, 70% of patients using steroid tape saw complete resolution of their lesions, compared to 25% using ointment alone.15PubMed Central. Steroid tape: A promising adjunct to scar management
The appeal of steroid tape for scars is that it combines compression, occlusion, and drug delivery in one step. The occlusion aspect is key because it forces the steroid into the tissue more effectively than an open cream application. For someone who has been applying hydrocortisone cream to a raised scar with underwhelming results, switching to a steroid tape formulation (or even covering a thin layer of cream with silicone sheeting to mimic occlusion) can improve penetration considerably. These products are not as widely available as standard hydrocortisone cream, but they are increasingly used in burn units and plastic surgery clinics.
When Topical Steroids Work Best as Part of a Combination
In clinical practice, topical corticosteroids are rarely the sole treatment for problematic scars. They tend to perform best as one piece of a multimodal approach. A protocol studied for preventing scar recurrence after surgical excision of keloids and hypertrophic scars combined intralesional steroid injections (given every two weeks for five sessions) with twice-daily corticosteroid ointment application for six months after suture removal. Recurrence rates at an average follow-up of 32 months were about 17% for hypertrophic scars and 14% for keloids, which are encouraging numbers for a condition that recurs in a majority of patients treated with excision alone.1PubMed Central. The application of corticosteroids for pathological scar prevention and treatment: current review and update
The topical ointment in that protocol likely served a maintenance role, keeping low-level steroid exposure going between and after the more aggressive injections. This is probably the most reasonable way to think about hydrocortisone cream in scar management: not as a standalone treatment with transformative effects, but as a supporting player that can reduce redness, ease itching, and maintain some suppressive pressure on collagen production while other treatments do the heavy lifting. For mild scars that are not keloids or significant hypertrophic scars, it may be all the treatment you need. For anything more severe, it is better as a complement to silicone products, pressure therapy, or clinical procedures like steroid injections or laser treatment.
What Hydrocortisone Cream Will Not Fix
Atrophic scars, the pitted or indented kind commonly left by acne or chickenpox, are not going to respond to hydrocortisone. These scars have the opposite problem from keloids: there is too little tissue, not too much. Applying a cream that suppresses collagen production to a scar caused by insufficient collagen is counterproductive. Atrophic scars are better addressed with treatments that stimulate collagen growth, such as microneedling, fractional laser resurfacing, or dermal fillers.
Old, stable scars that are flat and pale are also poor candidates. Once a scar has finished remodeling and the fibroblasts have settled down, there is no active inflammatory process for hydrocortisone to interrupt. The cream’s mechanism of action depends on there being active cellular processes to suppress. A scar that reached its final state years ago is essentially inert tissue, and no amount of topical steroid will change its structure.
Stretch marks, despite technically being a type of scar, do not respond well to hydrocortisone either. In fact, topical corticosteroids are known to cause stretch marks when overused, because they thin the dermis. Using a skin-thinning agent on tissue that is already structurally weakened is more likely to worsen than improve the problem. If you have stretch marks and reach for a steroid cream thinking of it as a scar treatment, put it back.